HOLX Stock Cash Flow Statements

Hologic Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Hologic Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-09-24	2022-06-25	2022-03-26	2021-12-25	2021-09-25	2021-06-26	2021-03-27	2020-12-26	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-09-24	2016-06-25	2016-03-26	2015-12-26	2015-09-26	2015-06-27	2015-03-28	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-23	2012-03-24	2011-12-24	2011-09-24	2011-06-25	2011-03-26	2010-12-25	2010-09-25	2010-06-26	2010-03-27	2009-12-26	2009-09-26	2009-06-27	2009-03-28	2008-12-27	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31	2006-12-30	2006-09-30	2006-06-24	2006-03-25	2005-12-24	2005-09-24	2005-06-25	2005-03-26	2004-12-25	2004-09-25	2004-06-26	2004-03-27	2003-12-27	2003-09-27	2003-06-28

operating activities
net income	-17,400,000	201,000,000	178,600,000	194,500,000	169,900,000	246,500,000	90,600,000	-40,500,000	218,500,000	187,400,000	118,700,000	228,400,000	455,700,000	499,200,000	328,800,000	268,100,000	619,400,000	653,400,000	493,600,000	136,200,000	94,900,000	385,800,000	-123,500,000	93,900,000	-272,600,000	98,600,000	50,500,000	112,900,000	-681,400,000	406,700,000	82,700,000	59,500,000	526,800,000	86,500,000	92,100,000	84,900,000	68,900,000	84,900,000	25,100,000	29,500,000	47,800,000	29,200,000	28,100,000	11,316,000	-16,765,000	-5,351,000	-1,113,902,000	-10,950,000	-51,104,000	3,118,000	-77,767,000	23,594,000	-40,273,000	20,812,000	27,569,000	36,196,000	82,445,000	10,940,000	-136,974,000	27,448,000	20,618,000	26,095,000	34,940,000	41,000,000	-2,300,170,000	47,993,000	-144,373,000	61,378,000	55,986,000	-358,608,000	32,110,000	24,748,000	21,634,000	16,086,000	-1,474,000	12,017,000	11,164,000	5,716,000	9,476,000	8,158,000	6,048,000	4,574,000	5,210,000	3,325,000	2,589,000	1,040,000	2,334,000	1,077,000
adjustments to reconcile net income to net cash from operating activities:
depreciation	24,100,000	23,300,000	24,100,000	22,600,000	23,000,000	29,600,000	22,900,000	22,400,000	21,600,000	22,700,000	22,000,000	22,300,000	22,600,000	22,300,000	23,800,000	22,700,000	20,400,000	21,100,000	20,300,000	20,500,000	20,700,000	21,600,000	22,800,000	22,900,000	23,100,000	23,700,000	23,800,000	25,800,000	25,000,000	27,000,000	26,100,000	24,000,000	19,100,000	20,400,000	21,000,000	21,100,000	20,300,000	19,900,000	20,700,000	20,100,000	20,400,000	20,300,000	22,000,000	23,702,000	24,061,000	24,937,000	25,013,000	24,287,000	21,876,000	24,342,000	23,744,000	15,926,000	16,071,000	16,110,000	17,908,000	17,482,000	16,694,000	16,862,000	17,437,000	17,439,000	16,695,000	16,892,000	18,544,000	17,258,000	15,596,000	15,797,000	13,782,000	14,270,000	14,202,000	10,159,000	3,709,000	3,547,000	3,414,000	3,621,000	3,814,000	2,246,000	1,768,000	1,664,000	1,648,000	1,641,000	1,520,000	1,612,000	1,451,000	1,399,000	1,373,000	1,489,000	1,418,000	1,513,000
amortization of acquired intangible assets	52,100,000	50,700,000	50,500,000	49,700,000	50,700,000	58,800,000	52,600,000	58,800,000	59,200,000	63,200,000
stock-based compensation expense	28,400,000	30,100,000	13,200,000	14,600,000	25,800,000	28,700,000	19,000,000	16,900,000	23,200,000	20,500,000	14,900,000	15,300,000	17,800,000	18,700,000	14,000,000	15,400,000	17,000,000	18,600,000	29,600,000	19,900,000	15,700,000	18,100,000	13,500,000	13,900,000	17,500,000	17,100,000	11,900,000	17,200,000	19,500,000	16,400,000	14,800,000	14,400,000	19,800,000	19,200,000	20,300,000	14,500,000	14,700,000	15,900,000	17,100,000	16,400,000	13,700,000	12,100,000	10,900,000	13,002,000	12,372,000	13,726,000	10,409,000	10,819,000	19,013,000	12,066,000	14,212,000	8,754,000	8,949,000	8,657,000	8,227,000	7,779,000	8,768,000	10,698,000	9,636,000	7,949,000	8,454,000	8,121,000	8,586,000	8,010,000	8,873,000	7,470,000	5,696,000	6,542,000	4,903,000	7,192,000	1,413,000	1,587,000	1,588,000	1,516,000
deferred income taxes	-62,700,000	-19,500,000		-5,500,000	-29,200,000	-17,600,000		-38,600,000	-35,400,000	-26,200,000		-18,700,000	-19,600,000	-21,900,000		-20,800,000	-11,500,000	-12,000,000		-19,100,000	283,700,000	-327,900,000		-21,500,000	-123,300,000	-50,000,000		-36,700,000	-42,900,000	-390,700,000		-42,000,000	-238,000,000	-24,600,000	-51,600,000	-39,500,000	-36,700,000	-28,000,000	-37,900,000	-31,800,000	-48,600,000	-30,500,000	-38,500,000	-39,812,000	-39,729,000	-125,059,000	-78,592,000	-26,889,000	-22,379,000	-70,123,000	-30,939,000	-21,165,000	-89,982,000	-13,106,000	-12,761,000	-31,908,000	16,377,000	-19,815,000	-73,422,000	-4,067,000	-36,129,000	-8,108,000	-4,738,000	3,697,000	-1,615,000	715,000	10,432,000	1,901,000	-2,696,000	-20,002,000	-11,028,000	21,000	15,887,000	993,000	-4,333,000	7,000	-1,000	-1,470,000
intangible asset impairment charges																						30,200,000
other adjustments and non-cash items	20,400,000	-19,100,000	13,500,000	9,400,000	-4,500,000	27,500,000	-1,700,000	1,000,000	500,000	29,100,000	-3,700,000	17,600,000	13,000,000	5,700,000	4,500,000	900,000	-10,600,000	29,500,000	3,700,000	8,800,000	14,300,000	500,000	6,200,000	5,900,000	-900,000	6,900,000	1,900,000	-500,000	6,100,000	1,200,000	7,000,000	4,100,000	3,700,000	-6,000,000	-4,100,000	200,000	2,500,000	-1,500,000
changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:
accounts receivable	-3,700,000	-41,700,000	43,500,000	17,600,000	18,100,000	-38,200,000	49,500,000	30,800,000	-36,800,000	-45,000,000	78,400,000	92,300,000	149,700,000	-48,100,000	-600,000	282,900,000	4,100,000	-175,500,000	-296,600,000	-130,200,000	-17,900,000	17,600,000	-66,800,000	-28,300,000	18,200,000	400,000	-24,400,000	-16,300,000	8,900,000	-6,400,000	-11,800,000	-57,700,000	6,500,000	21,500,000	-21,000,000	-3,800,000	-11,300,000	4,300,000	-33,800,000	200,000	13,000,000	-9,700,000	-20,500,000	6,856,000	5,990,000	15,554,000	-5,209,000	684,000	1,724,000	6,903,000	11,050,000	-14,482,000	-957,000	-6,616,000	-29,251,000	11,773,000	-6,118,000	6,465,000	-15,498,000	2,374,000	-7,750,000	663,000	18,431,000	22,426,000	11,462,000	5,262,000	-4,327,000	483,000	-22,615,000	-21,977,000	-17,435,000	-13,550,000	-9,409,000	1,124,000	1,699,000	1,837,000	-8,652,000	-4,429,000	-3,692,000	-1,554,000	-674,000	-3,390,000	-635,000	-5,408,000	4,995,000	-3,387,000	-3,383,000	1,831,000
inventories	-5,700,000	-36,100,000		-16,700,000	-17,400,000	-13,000,000		7,600,000	-9,100,000	-47,000,000		-60,400,000	-9,000,000	-17,400,000		-36,400,000	-24,800,000	-21,200,000		-14,700,000	-18,400,000	-14,900,000	18,700,000	-27,700,000	-26,100,000	-27,900,000	-11,300,000	-11,800,000	-4,200,000	-23,300,000	8,600,000	8,800,000	-8,300,000	-20,700,000	5,500,000	4,400,000	1,300,000	-3,600,000	11,000,000	3,900,000	10,300,000	18,700,000	-2,500,000	-18,373,000	-9,676,000	-14,151,000	13,105,000	15,779,000	2,285,000	-6,004,000	-3,215,000	2,930,000	-415,000	-11,474,000	2,573,000	-10,010,000	-12,025,000	-12,696,000	5,975,000	3,686,000	-2,939,000	-11,969,000	736,000	-6,712,000	-459,000	-8,707,000	8,420,000	-20,044,000	-7,204,000	-10,767,000	-10,106,000	68,000	6,689,000	-4,648,000	882,000	-7,543,000	-11,368,000	-4,994,000	-2,846,000	-4,732,000	-2,387,000	5,584,000	2,805,000	-543,000	1,328,000	-162,000	3,111,000	-1,009,000
prepaid income taxes	-36,400,000	29,200,000	52,200,000	41,400,000	-45,200,000	-70,100,000	2,100,000	7,000,000	-9,600,000	17,900,000	-12,800,000	-4,100,000	-1,800,000	-4,600,000	37,300,000	22,300,000	-55,500,000	8,900,000	6,800,000	17,100,000	-28,700,000	1,000,000	8,300,000	-3,200,000	-10,300,000	2,000,000	12,500,000	7,900,000	-37,900,000	8,100,000	-4,200,000	-4,900,000	1,200,000	-800,000	2,800,000	-1,500,000	-18,300,000	21,700,000	2,000,000	-2,600,000	-21,100,000	22,400,000	-12,000,000	-10,345,000	0	44,745,000	-11,878,000	53,678,000	-35,238,000	18,538,000	5,711,000	36,000	-16,000	340,000	-10,098,000	12,792,000			3,483,000				4,053,000	5,785,000
prepaid expenses and other assets	-4,400,000	13,200,000	11,500,000	8,300,000	-15,100,000	2,600,000	-1,000,000	14,100,000	-15,700,000	26,200,000	6,000,000	23,000,000	355,000,000	300,000	-34,000,000	14,400,000	-18,400,000	-18,300,000	3,800,000	27,600,000	-315,000,000	-2,600,000	5,800,000	-1,400,000	-8,600,000	-1,800,000	-4,500,000	9,400,000	-4,100,000	-5,000,000	2,000,000	-400,000	13,400,000	-17,400,000	11,300,000	-1,200,000	-7,300,000	-7,700,000	1,000,000	7,300,000	400,000	-3,000,000	3,500,000	4,031,000	7,662,000	2,107,000	-4,423,000	4,069,000	2,402,000	-1,177,000	68,450,000	4,930,000	-3,044,000	-530,000	-1,829,000	1,543,000			-691,000				-2,783,000	851,000
accounts payable	-31,000,000	36,200,000	-4,300,000	-200,000	19,500,000	7,200,000	-2,700,000	-7,100,000	-14,700,000	1,500,000	-16,900,000	-6,600,000	22,900,000	-13,800,000	11,000,000	-23,400,000	28,200,000	4,600,000	50,200,000	-7,200,000	7,500,000	-55,400,000	25,400,000	-3,700,000	-11,200,000	-16,000,000	23,500,000	9,900,000	-2,400,000	-7,100,000	17,700,000	-28,800,000	18,300,000	-17,800,000	25,700,000	12,800,000	6,500,000	-4,900,000	27,300,000	16,000,000	7,000,000	-24,800,000	10,100,000	14,017,000	-22,740,000	10,423,000	8,010,000	-1,477,000	-2,310,000	-10,629,000	11,923,000	-10,494,000	2,838,000	-499,000	10,950,000	-10,932,000	-4,057,000	6,628,000	1,087,000	2,937,000	985,000	2,142,000	-3,247,000	-2,245,000	-1,922,000	-5,467,000	-1,054,000	-3,718,000	-1,712,000	-3,705,000	4,212,000	1,748,000	5,443,000	2,862,000	-8,560,000	6,560,000	2,496,000	3,444,000	-1,578,000	2,835,000	3,267,000	-901,000	-351,000	1,438,000	-1,966,000	427,000	142,000	-233,000
accrued expenses and other liabilities	-39,100,000	-54,600,000	14,900,000	45,200,000	49,000,000	-35,700,000	-24,900,000	33,100,000	-23,200,000	800,000	7,200,000	-25,900,000	-39,500,000	42,400,000	22,700,000	22,500,000	-108,200,000	58,100,000	55,500,000	91,300,000	-28,200,000	-22,600,000	31,400,000	23,300,000	-19,600,000	-51,600,000	62,400,000	13,900,000	-71,400,000	48,900,000	-33,200,000	-536,500,000	537,300,000	14,600,000	10,900,000	36,800,000	7,700,000	-9,800,000	11,600,000	44,600,000	-14,300,000	-5,000,000	-1,400,000	22,611,000	-60,178,000	53,667,000	-29,765,000	43,899,000	-87,937,000	76,138,000	-81,247,000	-10,209,000	39,133,000	11,306,000	31,021,000	10,508,000	-2,362,000	1,402,000	7,235,000	-17,042,000	7,304,000	2,155,000	15,482,000	1,590,000
deferred revenue	23,900,000	-23,400,000	-10,600,000	11,200,000	19,300,000	-10,600,000	-31,600,000	3,500,000	40,200,000	2,300,000	-9,900,000	-9,300,000	11,900,000	-5,000,000	-8,600,000	15,800,000	17,300,000	-10,500,000	9,500,000	-300,000	16,100,000	-10,300,000	10,500,000	-4,800,000	5,400,000	3,300,000	-5,200,000	5,700,000	8,600,000	-10,600,000	-11,400,000	19,000,000	-3,700,000	-14,500,000	1,300,000	6,200,000	-7,200,000	-5,200,000	13,700,000	-4,900,000	8,500,000	-1,200,000	4,400,000	1,615,000	6,525,000	2,560,000	7,119,000	1,898,000	10,551,000	-6,243,000	1,516,000	5,586,000	1,818,000	3,813,000	-3,564,000	-5,081,000	6,851,000	1,313,000	848,000	-279,000	11,123,000	9,581,000	5,244,000	1,882,000	3,066,000	9,448,000	4,985,000	7,329,000	6,944,000	7,764,000	2,973,000	6,645,000	3,432,000	1,469,000	5,799,000	2,237,000	1,331,000	1,163,000	3,945,000	798,000	3,479,000	-83,000	647,000	503,000	445,000	1,927,000	691,000	296,000
net cash from operating activities	169,400,000	189,300,000	367,000,000	405,800,000	292,400,000	220,000,000	258,700,000	332,800,000	206,300,000	253,400,000	168,600,000	330,700,000	1,062,200,000	564,200,000	465,400,000	662,800,000	552,200,000	650,000,000	442,000,000	223,000,000	117,700,000	113,900,000	247,700,000	163,700,000	133,500,000	104,600,000	232,400,000	234,000,000	97,400,000	169,100,000	166,600,000	-411,700,000	83,800,000	169,600,000	226,700,000	246,100,000	150,100,000	164,300,000	232,500,000	242,300,000	157,800,000	153,500,000	131,700,000	158,385,000	69,049,000	149,266,000	77,998,000	246,296,000	14,503,000	155,025,000	85,591,000	71,796,000	101,104,000	111,731,000	118,909,000	119,924,000	81,870,000	135,321,000	118,771,000	117,842,000	94,122,000	125,977,000	150,741,000	154,473,000	120,264,000	120,887,000	89,995,000	106,570,000	118,301,000	49,730,000	49,214,000	23,818,000	49,075,000	31,143,000	1,725,000	26,320,000	1,474,000	1,605,000	11,115,000	10,713,000	17,280,000	5,265,000	13,038,000	1,548,000	10,508,000	788,000	4,678,000	10,062,000
investing activities
acquisition of business, net of cash acquired																																																								-72,072,000
acquisition of intangible assets	0	-15,400,000
sale of business, net of cash disposed			0	0	0	-31,300,000
capital expenditures	-15,500,000	-16,800,000	-16,400,000	-20,500,000	-12,800,000	-22,700,000	-36,300,000	-21,000,000	-18,700,000	-15,800,000		-14,700,000	-36,900,000	800,000		-19,500,000	-19,300,000	-32,400,000		-23,600,000	-18,200,000	-11,400,000		-14,800,000	-13,500,000	-9,500,000		-13,300,000	-14,400,000	-10,200,000
free cash flows	153,900,000	172,500,000	350,600,000	385,300,000	279,600,000	197,300,000	222,400,000	311,800,000	187,600,000	237,600,000		316,000,000	1,025,300,000	565,000,000		643,300,000	532,900,000	617,600,000		199,400,000	99,500,000	102,500,000		148,900,000	120,000,000	95,100,000		220,700,000	83,000,000	158,900,000
increase in equipment under customer usage agreements	-24,700,000	-14,800,000	-13,900,000	-13,400,000	-15,200,000	-15,300,000	-16,200,000	-15,500,000	-13,400,000	-13,300,000	-11,800,000	-11,000,000	-16,800,000	-17,000,000	-16,000,000	-15,600,000	-15,400,000	-12,400,000	-13,200,000	-11,400,000	-13,400,000	-20,100,000	-12,200,000	-11,000,000	-15,800,000	-13,100,000	-11,600,000	-11,400,000	-12,600,000	-11,600,000	-11,600,000	-12,900,000	-12,100,000	-13,200,000	-11,400,000	-13,500,000	-11,700,000	-10,600,000	-11,100,000	-10,500,000	-9,400,000	-10,300,000	-9,000,000	-8,936,000	-9,996,000	-7,968,000	-9,265,000	-10,956,000	-9,741,000	-11,214,000	-12,874,000	-13,425,000	-11,439,000	-7,886,000	-7,237,000	-7,610,000	-7,333,000	-5,698,000	-3,987,000	-4,884,000	-5,265,000	-4,512,000	-5,432,000	-6,687,000	-6,703,000	-3,964,000	-7,149,000	-6,711,000	-6,269,000	-4,854,000
strategic investments	-9,000,000	-6,000,000	0	-3,000,000
maturities of available-for-sale securities	48,000,000	32,000,000
other activity	-600,000	-700,000	-400,000	4,300,000	-5,500,000	-400,000	-300,000	-400,000	-4,800,000	-1,900,000	-500,000	-200,000			-100,000	-1,600,000	-300,000	-200,000	0	-1,300,000			-1,600,000	-1,700,000	-2,100,000	-1,500,000	-3,300,000	-1,700,000	-1,800,000	-400,000
net cash from investing activities	-324,300,000	-22,000,000	-595,700,000	-42,600,000	-38,500,000	-104,200,000	-56,000,000	-38,700,000	-16,400,000	-41,000,000	-32,100,000	-9,800,000	9,100,000	-173,500,000	-43,100,000	-758,400,000	-478,200,000	-49,900,000	-137,900,000	-36,300,000	78,300,000	-45,700,000	-80,800,000	-32,800,000	-36,400,000	-130,700,000	-107,500,000	-26,400,000	-35,100,000	-26,200,000	-107,800,000	-30,200,000	449,000,000	-25,200,000	-32,300,000	-21,600,000	-26,800,000	12,300,000	-29,300,000	-17,800,000	-17,000,000	-22,000,000	-15,100,000	-17,331,000	-20,186,000	-14,383,000	-21,333,000	-26,018,000	50,353,000	15,752,000	-3,798,860,000	-20,834,000	-6,489,000	-24,601,000	-20,914,000	-86,927,000	-122,414,000	-36,332,000	-96,923,000	-11,071,000	56,290,000	-15,276,000	-10,209,000	-18,268,000	-15,533,000	-17,509,000	-610,160,000	-14,714,000	21,429,000	-2,076,855,000	-48,657,000	874,000	-1,303,000	-10,140,000	-146,482,000	-25,196,000	-3,308,000	-31,690,000	-1,127,000	-7,186,000	-2,064,000	-3,117,000	-2,103,000	-1,544,000	-1,587,000	-1,387,000	-784,000	-1,800,000
financing activities
repayment of long-term debt	-9,400,000	-9,400,000	-9,400,000	-9,300,000	-9,400,000	-259,400,000	-3,700,000	-3,800,000	-3,700,000	-3,800,000	0	0	0	-1,387,500,000	-18,700,000	-18,800,000	-18,700,000	-18,800,000	-9,400,000	-9,300,000	-9,400,000	-9,400,000	0	0	0	-1,462,500,000	-9,400,000	-9,400,000	-9,300,000	-1,331,300,000	-28,100,000	-18,800,000	-18,700,000	-18,800,000	-18,800,000	-18,700,000	-18,700,000	-18,800,000	-1,050,000,000	-1,687,500,000	-28,700,000	-328,800,000	-16,200,000	-16,300,000	-41,250,000	-521,250,000		-16,250,000	-16,250,000	-16,250,000
payment of contingent consideration			0	0			0	0			0	0																																			-525,000	0	-39,025,000	-3,408,000			-47,575,000	-4,105,000	1,000	15,365,000	0	-19,660,000
repurchases of common stock	-200,000,000	-517,300,000	-58,300,000	-100,000,000	0	-676,800,000	-211,200,000	-113,600,000	-50,000,000	-100,000,000	-175,100,000	0
proceeds from issuance of common stock pursuant to employee stock plans	8,700,000	12,200,000		6,800,000	8,900,000	9,500,000		9,300,000	13,300,000	15,100,000		9,600,000	10,900,000	6,400,000		6,000,000	10,300,000	23,300,000		18,100,000	17,900,000	18,700,000		7,100,000	15,300,000	13,500,000		7,800,000	6,800,000	9,500,000
payment of minimum tax withholdings on net share settlements of equity awards	-200,000	-21,700,000	-800,000	-300,000	-100,000	-16,200,000	-300,000	-500,000	-200,000	-23,000,000	-300,000	-100,000	-100,000	-22,400,000	-600,000	-200,000	-300,000	-46,400,000	-1,700,000	-100,000	-1,600,000	-10,900,000	-400,000	-500,000	-300,000	-11,600,000	-600,000	-500,000	-1,300,000	-14,300,000	-400,000	-1,700,000	-1,200,000	-16,400,000	-300,000	-500,000	-700,000	-14,900,000	-300,000	-500,000	-1,500,000	-10,600,000	-600,000	-37,000
payments under finance lease obligations	-800,000	-800,000	-900,000	-1,000,000	-1,000,000	-900,000	-700,000	-1,000,000	-1,300,000	-1,000,000	-1,000,000	-1,100,000	-1,100,000	-600,000	-900,000	-600,000	-400,000	-500,000	-500,000	-400,000	-400,000	-400,000
net cash from financing activities	-201,700,000	-537,000,000	-56,800,000	-103,800,000	-4,200,000	-943,800,000	-210,600,000	-109,600,000	-49,500,000	-113,500,000	-169,800,000	-240,200,000	-202,500,000	-143,500,000	-82,000,000	109,600,000	-129,200,000	-428,200,000	-350,900,000	-241,700,000	222,600,000	-289,900,000	9,200,000	-104,500,000	-8,000,000	-328,200,000	-27,900,000	-241,500,000	-115,100,000	-20,300,000	-110,600,000	-113,100,000	-45,100,000	-40,400,000	-87,500,000	-98,600,000	-458,000,000	-15,600,000	-593,200,000	-11,200,000	-11,100,000	-321,200,000	-10,700,000	6,822,000	-6,783,000	-514,439,000	-193,425,000	-5,481,000	-37,283,000	-12,581,000	3,367,862,000	363,000	-33,812,000	-6,314,000	1,359,000	7,387,000	5,007,000	-6,079,000	1,179,000	-46,003,000	-63,937,000	-58,814,000	-92,262,000	-108,853,000	-58,640,000	-28,869,000	495,226,000	-69,543,000			7,000,000	14,543,000	-30,745,000	-13,258,000	63,513,000	831,000	15,578,000	10,677,000	1,774,000	3,372,000	8,000,000	1,775,000	438,000	820,000	1,760,000	902,000	1,327,000	233,000
effect of exchange rate changes on cash and cash equivalents	4,000,000	-8,400,000	6,600,000	-300,000	-1,800,000	4,400,000	-1,400,000	-1,700,000	500,000	2,900,000	-2,500,000	3,800,000	1,200,000	3,300,000	2,400,000	-2,800,000	2,900,000	-4,200,000	3,600,000	-600,000	-300,000	1,400,000			800,000	-1,300,000	-5,700,000	-4,900,000	2,600,000	1,200,000	4,000,000	8,800,000	900,000	-6,400,000	0	-700,000	700,000	-2,000,000	-3,700,000	1,200,000	-3,200,000	-2,400,000	-2,300,000	92,000	-46,000	-446,000	806,000	-1,349,000	-1,048,000	-155,000	755,000	-804,000	676,000	-66,000	-823,000	499,000	419,000	-499,000	1,230,000	-715,000	-202,000	-31,000	1,195,000	-859,000	-342,000	1,309,000	737,000	-253,000	-990,000	-462,000	-954,000	64,000	165,000	-359,000
net decrease in cash and cash equivalents	-352,600,000	-378,100,000																				-220,300,000																			126,500,000	-192,100,000																																												-162,000
cash and cash equivalents, beginning of period*	0	2,160,200,000	0	0	0	2,755,700,000
cash and cash equivalents, end of period	-352,600,000	1,782,100,000		259,100,000	247,900,000	1,932,100,000		182,800,000	140,900,000	2,441,300,000	-35,800,000	84,500,000	870,000,000	1,420,800,000	342,700,000	11,200,000	-52,300,000	868,700,000	-43,200,000	-55,600,000	418,300,000	381,500,000	173,900,000	26,900,000	89,900,000	311,100,000	91,300,000	-38,800,000	-50,200,000	664,400,000	-47,800,000	-546,200,000	488,600,000	646,000,000	106,900,000	125,200,000	-334,000,000	650,300,000	-393,700,000	214,500,000	126,500,000	544,000,000	103,600,000	147,978,000	42,034,000	442,488,000		213,448,000	26,525,000	718,471,000		50,521,000	61,479,000	793,082,000		40,883,000	-35,118,000	608,036,000		60,053,000	86,273,000	345,042,000		26,493,000	45,749,000	171,479,000				154,663,000		39,299,000	17,192,000	37,309,000		1,855,000	13,771,000	94,514,000		6,556,000	22,989,000	72,702,000		811,000	11,118,000	45,015,000	5,303,000	8,453,000
intangible asset impairment charge						4,300,000																					0	0
acquisition of businesses, net of cash acquired		-300,000									0	-200,000	-1,100,000	-157,300,000	-1,400,000	-723,300,000	-435,100,000	-4,900,000	-76,200,000	0	-31,400,000	-11,800,000	-1,200,000	-800,000	-2,000,000	-106,600,000	-72,100,000	0	-300,000	-4,100,000	-79,200,000
deferred income taxes and other non-cash taxes
intangible assets and equipment impairment charges							0
loss on assets held-for-sale
contingent consideration fair value adjustments
debt extinguishment loss											0	0			0	0	0	21,600,000												1,000,000						0				18,200,000	0	6,700,000		23,000	4,437,000	2,940,000	5,962,000	0
changes in operating assets and liabilities, excluding the effect of acquisitions:
inventory
purchases of available-for-sale securities
proceeds from the department of defense							0	0			0	16,300,000
purchase of intellectual property			0												0	0							0												0	0
proceeds from long-term debt, net of issuance costs											0	0	0	1,491,200,000
repayments under accounts receivable securitization agreement																			0	0
repayment of acquired long-term debt											0
payment of deferred acquisition consideration							0	0	0	-800,000									0	0	-7,700,000	-16,600,000	-3,900,000																				0	-35,000
net proceeds from issuance of common stock under employee stock plans
net increase in cash and cash equivalents			-278,900,000	259,100,000	247,900,000	-823,600,000	-9,300,000	182,800,000	140,900,000	101,800,000	-35,800,000	84,500,000	870,000,000	250,500,000	342,700,000	11,200,000	-52,300,000	167,700,000	-43,200,000	-55,600,000			173,900,000	26,900,000	89,900,000	-355,600,000	91,300,000	-38,800,000	-50,200,000	123,800,000	-47,800,000	-546,200,000	488,600,000	97,600,000	106,900,000			159,000,000	-393,700,000				103,600,000	147,968,000	42,034,000	-380,002,000	-135,954,000	213,448,000	26,525,000	158,041,000	-344,652,000	50,521,000	61,479,000	80,750,000	98,531,000	40,883,000	-35,118,000	92,411,000	24,257,000	60,053,000	86,273,000	51,856,000	49,465,000	26,493,000	45,749,000	75,818,000					6,603,000	39,299,000	17,192,000	7,386,000	-80,217,000	1,855,000	13,771,000	-19,480,000	11,747,000	6,556,000	22,989,000	4,367,000	11,391,000	811,000			5,303,000	8,453,000
cash and cash equivalents, end of period*
intangible asset and equipment impairment charges																			0	0			241,600,000	0
contingent consideration - fair value adjustments								0
contingent consideration - fair value adjustment
purchase of strategic equity investments						-34,500,000
contingent consideration-fair value adjustments
purchase of equity investment							0	0	0	-10,000,000
proceeds from senior notes, net of issuance costs
repayment of senior notes															0	0	0	-970,800,000									0	0
repayments under revolving credit line																			-250,000,000
proceeds from accounts receivable securitization agreement															0				0	0															0
purchase of non-controlling interest															0				0	-100,000	-300,000	-1,400,000
cash and cash equivalents, beginning of period							0	0	0	2,339,500,000	0	0	0	1,170,300,000	0	0	0	701,000,000	0	0	0	601,800,000	0	0	0	666,700,000	0	0	0	540,600,000	0	0	0	548,400,000	0	0	0	491,300,000	0	0	0	736,100,000	0	10,000	0	822,490,000		0	0	560,430,000		0	0	712,332,000		0	0	515,625,000		0	0	293,186,000		0	0	95,661,000				100,403,000		0	0	29,923,000		0	0	113,994,000		0	0	68,335,000		0	0	45,177,000	0	0
repayment under accounts receivable securitization agreement
amortization																															94,400,000	94,300,000	76,000,000	94,900,000	93,600,000	99,800,000	93,700,000	96,000,000	101,600,000	100,400,000	106,200,000	101,700,000	109,400,000	110,235,000	105,983,000	102,882,000	107,611,000	104,668,000	104,400,000	103,813,000	90,904,000	61,013,000	60,970,000	61,013,000	60,470,000	59,671,000	59,041,000	56,608,000	55,006,000	57,097,000	57,103,000	57,099,000	52,094,000	53,798,000	50,453,000	50,384,000	32,190,000	30,841,000	31,102,000	26,404,000	4,182,000	4,074,000	4,005,000	4,610,000	3,841,000	971,000	914,000	915,000	286,000	282,000	295,000	290,000	474,000	460,000	472,000	471,000	443,000	334,000
net proceeds from sale of business																			-3,400,000	0
purchase of property and equipment																															-22,000,000	-11,300,000	-13,000,000	-11,500,000	-20,300,000	-7,600,000	-10,300,000	-9,100,000	-20,200,000	-7,900,000	-9,200,000	-10,800,000	-13,400,000	-11,123,000	-11,360,000	-8,417,000	-7,838,000	-15,228,000	-14,655,000	-11,233,000	-12,457,000	-6,460,000	-7,442,000	-6,790,000	-5,891,000	-7,238,000	-7,269,000	-7,387,000	-8,324,000	-7,394,000	-6,719,000	-5,573,000	-6,548,000	-8,251,000	-7,059,000	-9,499,000	-10,898,000	-13,328,000	-16,614,000	-12,444,000	-6,082,000	-7,532,000	-3,296,000	-5,930,000	-4,613,000	-3,560,000	-1,567,000	-3,249,000
proceeds from revolving credit line																			0	0																			183,000,000
amortization of acquired intangibles												87,100,000	83,500,000	85,700,000		78,400,000	74,800,000	71,700,000		73,100,000	73,000,000	72,800,000		90,400,000	94,500,000	95,100,000		94,700,000	94,500,000	94,200,000
payment of acquired long-term debt													0	-63,600,000						0			0	0	0	-2,500,000
debt extinguishment losses														700,000									0	0	0	800,000	0	0
repayment under revolving credit line																0	0	-250,000,000
repurchase of common stock														-167,000,000		-188,300,000	-120,100,000	-101,300,000		100,000	-267,600,000	-80,900,000	0	-50,000,000	-3,100,000	-147,000,000	-88,500,000	-96,600,000							0	-114,100,000
purchase of equity method investment in ssi
loans to ssi
purchase of interest rate caps																							0	0			0												-7,100,000	0
proceeds from senior notes																0	0	950,000,000									0	0	1,000,000,000	350,000,000
payment of debt issuance costs																0	0	-13,700,000					0	0	0	-2,700,000	0	0	-11,600,000	-11,900,000									-14,400,000				0				-2,421,000				-73,500,000	-2,086,000			0	0	0	-5,327,000
purchase of insurance contracts																				0	0	-2,400,000																									0	0	0	-4,000,000					0	0	0	-5,322,000	0	0	0	-5,322,000	0	0
adjustments to reconcile net income income to net cash from operating activities:
goodwill impairment charge																											0	0																																			0	0
purchase of cost-method investment																							0	0			0	0																								0	-100,000	-150,000		0	51,000	-150,000		-246,000	-350,000	-125,000
purchases of insurance contracts																																				0
proceeds from long-term debt																							0	0	0	1,500,000,000	0	0	0	1,500,000,000
payments to extinguish convertible notes																											0	-243,400,000	-5,900,000	-296,900,000	-106,100,000	-269,100,000	-14,600,000	-6,400,000	-81,300,000	0
payoff of acquired long-term debt
payments to repurchase common stock pursuant to asr agreement																				0	0	-205,000,000
proceeds from amounts borrowed under revolving credit line																							0	0	0	480,000,000	190,000,000	250,000,000	215,000,000	495,000,000	220,000,000				0	0
repayments of amounts borrowed under revolving credit line																								-85,000,000	0	-695,000,000		-165,000,000	-180,000,000	-720,000,000
proceeds from amounts borrowed under accounts receivable securitization agreement																						16,000,000
non-cash interest expense																							2,400,000	2,200,000	1,800,000	2,200,000	1,900,000	1,900,000	2,500,000	8,700,000	10,500,000	12,000,000	12,600,000	14,300,000	13,300,000	12,700,000	12,900,000	13,200,000	14,300,000	16,300,000	16,500,000	16,700,000	16,500,000	16,380,000	16,152,000	19,668,000	19,979,000	19,811,000															5,276,000	5,721,000	3,902,000	2,843,000	4,506,000	3,624,000	6,758,000	5,653,000	46,000	46,000	46,000	43,000
fair value write-up of inventory sold																															17,400,000	19,900,000															0	0	22,521,000	29,876,000					0	0	1,961,000	1,337,000
gain on sale of business																																0
proceeds from sale of business																															0	0
proceeds from sale of available-for-sale marketable securities																											0	0	0	100,000	0	5,300,000
repayment of amounts borrowed under revolving credit line																																			0	-175,000,000
proceeds from accounts receivable securitization program																											5,200,000				0	40,000,000
repayments under accounts receivable securitization program
payments under capital lease obligations																							-400,000	-500,000	-400,000	-400,000	-400,000	-500,000	-400,000	-400,000	-500,000
fair value write-up of acquired inventory sold																								1,800,000	1,800,000	1,800,000
repayment of amounts borrowed under accounts receivable securitization agreement
repayment of amounts borrowed under accounts receivable securitization program																																-4,000,000	-32,000,000	-12,000,000
gain on sale of investments
sales of mutual funds																																			0	0			2,300,000	0	1,300,000	6,400,000	0	3,836,000	2,673,000	15,891,000
net gains on sale of marketable securities																																0
equity investment impairment charges
(gain) loss on sale of businesses
net proceeds from issuance of common stock pursuant to employee stock plans																															6,500,000	15,900,000	13,400,000	13,200,000	11,100,000	8,400,000	7,900,000	11,100,000	19,600,000	13,000,000	22,200,000	15,200,000	5,600,000	22,082,000	40,812,000	12,906,000	23,880,000	13,597,000	24,846,000	12,777,000	6,853,000	1,352,000	18,762,000	1,627,000	1,326,000	10,670,000	10,464,000	2,944,000	1,300,000	1,071,000	8,317,000	1,906,000
increase in other assets																																-3,800,000	-900,000	-900,000	-600,000	-500,000	-800,000	900,000			300,000	-900,000	-400,000	-1,068,000	-1,503,000	-429,000	-3,014,000	417,000																		-3,101,000	1,473,000	-3,811,000	264,000	-4,291,000	3,929,000	-5,098,000	-157,000	-4,210,000	4,951,000	-3,128,000	-1,741,000	-847,000	-72,000	-62,000	-840,000	-198,000				32,000		37,000
gain on sale of available-for-sale marketable security																																			0	0	0	-25,100,000
changes in operating assets and liabilities:
proceeds from sale of available-for-sale marketable security																																		400,000	0	0	0	31,100,000
excess tax benefit related to equity awards																																			-1,800,000	-1,300,000	-800,000	-7,100,000	-2,700,000	-2,000,000	-3,000,000	-3,000,000	-500,000	-1,066,000	-1,175,000	-2,959,000	-2,045,000	-957,000	-2,252,000	-2,185,000	-2,415,000	-1,108,000	-958,000	-1,725,000
asset impairment charges																																											5,100,000	-8,000	30,176,000	3,132,000
loss on disposal of property and equipment																																						1,300,000	2,100,000	1,300,000	1,500,000	1,700,000	2,000,000	1,662,000	2,027,000	1,411,000	1,252,000	1,475,000	1,292,000	906,000	1,407,000	1,089,000	940,000	373,000	819,000	525,000	570,000	725,000		684,000	495,000	1,124,000		543,000					239,000	57,000	290,000	432,000	-20,000	32,000	165,000	156,000	75,000	24,000
loss on sale of businesses
net (purchases) sales of insurance contracts																																							0	0	0	-6,400,000
purchases of mutual funds																																											0	32,000	0	-29,732,000
loss on sale of business
repurchase of convertible notes																																						-100,000
gain on sale of intellectual property																																															0	0	0	-53,884,000	0	0			0	0
fair value adjustments to contingent consideration																																															0	471,000	799,000	10,040,000	3,432,000	-13,276,000	43,188,000	5,122,000	-4,470,000	629,000
impairment of goodwill
payment of additional acquisition consideration																																															0	0	0	-16,808,000	0	0	0	-9,784,000	0
proceeds from sale of intellectual property																																															0	0	0	60,000,000	0	0			0	0	12,500,000	750,000	750,000	750,000	750,000	750,000	750,000	750,000			0
(purchase) sale of a cost-method equity investment
repayment from revolving credit line
cost-method equity investment impairment charges																																											0
loss on disposal of business
other																																								-200,000	-500,000	1,200,000	-10,400,000	-656,000	222,000	-966,000	370,000	577,000	3,125,000	-1,149,000
net proceeds from long-term debt
acquired in-process research and development
gain on sale of cost-method equity investment																																															0
changes in operating assets and liabilities, net of effects from acquisitions:
proceeds from sale of business, net of cash transferred																																											7,700,000	-31,000	0	2,431,000	-1,116,000	0	84,762,000	1,488,000
net sales (purchases) of insurance contracts																																											0	-41,000	0	13,841,000
acquisition of in-process research and development assets
purchase of cost-method equity investments
sale of a cost-method equity investment
acquisition of businesses
cost-method equity investment impairment
acquisition of a business
payment of debt issuance cost
purchase of cost method investments																																																	0	-3,625,000
payment of employee restricted stock minimum tax withholdings																																														-9,054,000	-154,000	-2,130,000	-2,087,000	-7,885,000	-3,000	-11,000	-135,000	-5,561,000
impairment of intangible assets
cost method equity investment impairment
purchase of licensed technology and other intangible assets																																																															1,176,000	-6,388,000	-88,000	-938,000
sale of cost method investment
purchases of cost method investments
repayment of long-term debt and notes payable
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
intangible asset impairment
non-cash restructuring charges																																																7,000			466,000	1,119,000
purchase of cost-method investments
sale of a cost-method investment
deferred acquisition consideration
non-cash interest expense – amortization of debt discount and deferred financing costs																																																		20,679,000		16,001,000	18,921,000	19,960,000		19,198,000	18,694,000	19,471,000		23,753,000	22,053,000	21,073,000
decrease in other assets																																																		1,144,000
non-cash interest expense—amortization of debt discount and deferred financing costs
impairment of cost-method investments																																																							0
(gain) loss on divestiture
other non-cash activity																																																			-1,977,000	1,552,000	-1,318,000	-1,825,000	2,632,000	915,000	-1,458,000	-642,000	-379,000	-250,000	-401,000	2,038,000	-1,233,000	-1,085,000
divestiture activities, net of cash transferred
proceeds from sale of cost method investment																																																																			0				0	0
increase in restricted cash																																																																						-34,666,000
loss on debt extinguishment
impairment of cost-method equity investment
changes in operating assets and liabilities, net of acquisitions:
divestiture of business, net of cash transferred to the buyer																																																								0
purchase of other intangible assets																																																								0				0	0	-500,000
other assets
repayments of notes payable																																																							-347,000	-342,000	-338,000	-335,000	-333,000	-327,000	-335,000	-1,842,000	-7,959,000				-541,000	-311,000	-1,753,000	-290,000																		-212,000
contingent consideration payments
loss on extinguishment of debt																																																							0	0	0	29,891,000
impairment of cost-method investment																																																									0	2,100,000
decrease in restricted cash																																																					-8,000	9,000		-7,000	386,000	6,000		25,000	38,000	6,000		2,483,000
acquisition of in process research and development assets
decrease (increase) in restricted cash																																																																		483,000
repayments under credit agreements
payments upon conversion of cytyc convertible notes
payments of employee restricted stock minimum tax withholdings
excess tax benefit related to exercise of non-qualified stock options																																																								-1,501,000	-1,115,000	-652,000	-215,000	-338,000	-709,000	-781,000	-2,450,000	-229,000
loss on divestiture																																																											0	0
proceeds from sale of cost-method investment
repayments under credit agreement																																																												-46,969,000	-72,554,000	-54,644,000		-107,622,000	-58,643,000	-29,042,000		-89,647,000	-205,000,000	-2,055,353,000
purchase of non-controlling interests																																																												0	0	-2,683,000
payment of employee restricted stock tax withholding requirements																																																								-147,000	-6,234,000	-4,013,000		-116,000	-74,000	-2,332,000
contingent consideration adjustment to fair value																																																										1,096,000
prepaid income tax																																																										3,675,000			-143,000	172,000
prepaid expenses and other current assets																																																										-85,000			-2,978,000	-320,000				297,000	-4,560,000	-8,222,000	-1,588,000	4,404,000	1,017,000	-1,028,000	-3,943,000	-27,000	-2,136,000	6,622,000	-4,746,000	352,000	-3,266,000	-78,000	598,000	-313,000	542,000	368,000	-394,000	-72,000	-865,000	6,839,000
divestiture of business																																																										1,129,000
loss on disposal and impairment of property and equipment
deferred gain																																																											0	0							0	2,000,000
purchases of investment securities																																																																			2,374,000	0	0	-2,637,000
proceeds from sales and maturities of investment securities																																																																			0	0	0	2,638,000
proceeds from issuance of convertible notes, net of issuance costs																																																																			0	0	-24,000	1,688,998,000
proceeds under credit agreements, net of issuance costs
proceeds from note payable
financing costs on credit agreement																																																															0	-36,000	-31,000	-283,000
payments of employee restricted stock tax withholdings																																																															-3,000
fair value write-up of third wave inventory sold
charge for impairment of acquired intangible assets																																																																0				0	0	2,900,000
other-than-temporary impairment charge on cost-method investments
divestiture of business, net of cash transferred to buyer																																																												0
additional business acquisition consideration																																																																0	97,000	-326,000
payment upon conversion of cytyc convertible notes																																																																				0
other-than-temporary impairment charge on a cost-method investment
fair value write-up of cytyc and third wave inventory sold
impairment charges of intangibles
proceeds from sale of building
purchase of cost method investment																																																															-150,000	-175,000
acquisition of non-controlling interest
deferred acquisition costs
purchase of treasury shares to settle minimum withholding taxes
cash flows from operating activities:
fair value write-up of third wave and cytyc inventory																																																																250,000
charge for in-process research and development																																																																				0	0	370,000,000					15,100,000	600,000	0	4,200,000
other-than-temporary impairment charges on cost-method investments
changes in assets and liabilities, net of acquisitions:
cash flows from investing activities:
merger with cytyc corporation, net of cash acquired
cash flows from financing activities:
proceeds under credit agreement, net of issuance costs																																																																				0	-263,000	2,335,942,000
proceeds from notes payable
net proceeds from sale of common stock pursuant to employee stock plans																																																																347,000
proceeds from sale of property and equipment
increase in notes payable																																																																				0	172,000	2,055,000
repayments of notes payable and capital leases																																																																	-1,283,000	-290,000
supplemental disclosure of non-cash financing activities:
issuance of common stock upon conversion of cytyc convertible notes																																																																						82,620,000
business acquisition, net of cash acquired:
fair value of tangible assets acquired
fair value of liabilities assumed
fair value of stock issued																																																																											-311,961,000
fair value of options exchanged
cost in excess of fair value of assets
fair value of acquired identifiable intangible assets
in-process research and development
deferred tax liability
less cash and cash equivalents and investments acquired
less acquisition costs paid prior to september 29, 2007
net cash paid for acquisition																																																																											153,320,000									0
fair value write-up of cytyc and third wave inventory																																																																		584,000
non-cash interest income																																																																		-70,000
increase in unrecognized income tax benefits																																																																		1,200,000
tax benefit related to exercise of non-qualified stock options																																																																		-78,000						-13,987,000	0	-2,244,000		1,116,000	22,310,000	-5,671,000
loss on disposal of property and equipment and intangible assets																																																																		231,000	25,000
income tax refundable																																																																		17,748,000	20,257,000	795,000	34,165,000	19,191,000
accrued expenses																																																																		-24,763,000	-7,711,000	24,001,000	-1,008,000	-30,435,000	43,526,000	9,467,000	309,000	5,706,000	-4,939,000	692,000	18,723,000	24,000	-315,000	3,333,000	5,093,000	-2,139,000	2,864,000	-25,000	1,636,000	-976,000	766,000	-641,000
increase in other liabilities																																																																		-164,000	-8,590,000	5,094,000	953,000	1,737,000
net proceeds from sale of common stock pursuant to stock plans																																																																		668,000	2,291,000	6,386,000	13,508,000	148,829,000	1,187,000	923,000	7,564,000	904,000	657,000	366,000	4,610,000	5,006,000	2,364,000
impairment charge on sale of intellectual property
tax benefit related to exercise of stock options
impairment charge on acquired intangibles
net cash paid for acquisition of intangible assets																																																																											0	0	0	-27,594,000
acquisition of minority interest
increase in note payable
supplemental disclosure of cash flow information:
cash paid during the period for income taxes																																																																						12,896,000	2,063,000	3,490,000	2,167,000	624,000	1,021,000	688,000	25,000	83,000	372,000	633,000	8,000	105,000	170,000	183,000	33,000	62,000	78,000	57,000
cash paid during the period for interest																																																																						23,058,000	313,000	195,000	804,000	934,000	901,000	117,000	19,000	40,000	53,000	29,000	86,000	17,000	18,000	21,000	23,000	29,000	-29,000	71,000
supplemental disclosure of non-cash investing activities:
additional business acquisition contingent consideration
exchange of note receivable for intangible assets																																																																											0	4,000	0	5,424,000
business acquisitions, net of cash acquired:
liabilities assumed																																																																											-99,043,000									0
cost in excess of fair value of assets acquired
acquired identifiable intangible assets
less cash and cash equivalents acquired
net cash paid for business acquisition
fair value write-up of cytyc inventory
acquisition of cytyc corporation, net of cash acquired																																																																				-2,000	-7,000	-2,022,338,000
fair value write up of cytyc inventory																																																																					825,000	41,500,000
payment upon conversion of cytyc convertible note																																																																						-38,334,000
net cash from (used) in financing activities																																																																						2,081,847,000
net increase in cash and cash equivalent																																																																						54,260,000
tax benefit related to exercise of non qualified stock options
business acquisitions, net of cash acquired
additional acquisition contingent consideration
increase in deferred revenue
proceeds under credit facility
repayments under credit facility
in process research and development																																																																											15,100,000
less cash acquired																																																																											6,769,000
operating activities:
changes in assets and liabilities-
investing activities:
business acquisition, net of cash acquired
financing activities:
repayment under credit facility																																																																								0	-40,000,000	-15,000,000
repayment under note payable																																																																								1,133,000
supplemental disclosure of noncash investing activities:
borrowing under note payable
repayment of note payable																																																																										-1,406,000						-118,000	-119,000	-120,000		-157,000	-163,000	-177,000
net cash paid for acquisition of distributor																																																																																			0	0
noncash interest expense																																																																															31,000	30,000	41,000	31,000				31,000	21,000	55,000
increase in deferred tax asset related to exercise of non-qualified stock options																																																																												-1,116,000
compensation expense related to issuance of equity awards
acquisition deposit
disposal of property and equipment
effect of exchange rate changes on cash																																																																												-100,000	27,000	-72,000	-15,000	-343,000	-227,000	444,000	18,000	-13,000	437,000	-465,000	82,000	-42,000
fair value of tangibles assets acquired
purchase price payable
compensation expense related to issuance of stock options																																																																													738,000	667,000
changes in assets and liabilities:
adjustments to reconcile net income to net cash from operating activities-
purchases of property and equipment																																																																																-1,827,000	-1,579,000	-3,148,000		-1,583,000	-1,273,000	-1,419,000		-1,837,000
disposals of property and equipment																																																																																123,000	355,000	229,000
net cash paid for acquisition:
fair value of assets acquired
costs in excess of net assets of distributor acquired																																																																																				0
net proceeds from sale of common stock																																																																																	8,119,000	1,895,000	1,024,000	977,000	1,923,000	1,079,000	1,391,000	445,000
cash paid for acquisition
adjustments to reconcile net income to net cash from operating activities
loss on sale/leaseback
proceeds from sale/leaseback, net of costs
decrease (increase) in other assets																																																																																			65,000	39,000
repayments of line of credit
issuance of note payable
supplemental disclosure of noncash financing activities:
stock issued for employee compensation
non cash interest expense
less: cash acquired
reversal of previously recorded trex reserves
compensation expense related to issuance of common stock and stock options
proceeds from settlement of trex purchase price
(repayments) borrowings under lines of credit
repayments of note payable
issuance of note payable to fleet business credit corp. for litigation settlement
repayments under line of credit

We provide you with 20 years of cash flow statements for Hologic stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hologic stock. Explore the full financial landscape of Hologic stock with our expertly curated income statements.

The information provided in this report about Hologic stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.